Alper R H, Schmitz T M
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66160-7417, USA.
Brain Res. 1996 Apr 15;716(1-2):224-8. doi: 10.1016/0006-8993(96)00069-8.
Studies determined if estradiol modulates cardiovascular responses evoked by administration of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), a 5-HT1A receptor agonist, into the lateral cerebral ventricle. 8-OH-DPAT (100 nmol) produced equivalent decreases in blood pressure in male and ovariectomized female (OVX) rats with or without estradiol replacement. By contrast, the bradycardia elicited by 8-OH-DPAT (3-100 nmol) was greatest in OVX rats with estradiol. Estradiol did not alter the bradycardia produced by electrical stimulation of the vagus nerve. In summary, estradiol selectively enhanced the bradycardia elicited by 8-OH-DPAT suggesting that estrogen modulates the function of central 5-HT1A receptors regulating heart rate.
研究确定雌二醇是否调节通过向侧脑室注射5-羟色胺1A受体激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)所诱发的心血管反应。无论有无雌二醇替代,8-OH-DPAT(100纳摩尔)在雄性和去卵巢雌性(OVX)大鼠中均可使血压产生同等程度的下降。相比之下,8-OH-DPAT(3 - 100纳摩尔)所诱发的心动过缓在接受雌二醇的OVX大鼠中最为明显。雌二醇并未改变电刺激迷走神经所产生的心动过缓。总之,雌二醇选择性地增强了8-OH-DPAT所诱发的心动过缓,提示雌激素调节着中枢5-羟色胺1A受体调节心率的功能。